{"id":"https://openalex.org/W4362539997","doi":"https://doi.org/10.1158/2326-6066.22538614","title":"Supplementary Tables 1 - 4 from Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab","display_name":"Supplementary Tables 1 - 4 from Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362539997","doi":"https://doi.org/10.1158/2326-6066.22538614"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.22538614","doi":"https://doi.org/10.1158/2326-6066.22538614","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538614","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.22538614","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082108817","display_name":"Serena S. Kwek","orcid":"https://orcid.org/0000-0001-5097-2711","observed_orcids":["https://orcid.org/0000-0001-5097-2711"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serena S. Kwek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112239073","display_name":"Jera Lewis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jera Lewis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425554","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-3617-2627","observed_orcids":["https://orcid.org/0000-0002-3617-2627","https://orcid.org/0000-0003-2756-2620","https://orcid.org/0009-0001-8129-4308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039728792","display_name":"VIVIAN K. WEINBERG","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivian Weinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046828727","display_name":"Samantha K. Greaney","orcid":"https://orcid.org/0000-0002-1841-600X","observed_orcids":["https://orcid.org/0000-0002-1841-600X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samantha K. Greaney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066372195","display_name":"Andrea Lynne Harzstark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea L. Harzstark","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024203592","display_name":"Amy Lin","orcid":"https://orcid.org/0000-0001-7757-6719","observed_orcids":["https://orcid.org/0000-0001-7757-6719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy M. Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012804612","display_name":"Charles J. Ryan","orcid":"https://orcid.org/0000-0002-2081-3557","observed_orcids":["https://orcid.org/0000-0002-2081-3557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles J. Ryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric J. Small","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5073970384","display_name":"Lawrence H. Fong","orcid":"https://orcid.org/0000-0002-6428-428X","observed_orcids":["https://orcid.org/0000-0002-6428-428X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Fong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.859000027179718},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9959999918937683},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.796999990940094},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7229999899864197},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.890999972820282},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.7990000247955322},{"id":"https://openalex.org/keywords/t-cell-subsets","display_name":"T cell subsets","score":0.8529999852180481},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.5}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9281630516052246},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7218305468559265},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6815696954727173},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.6428341269493103},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6199818849563599},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5399870872497559},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5281170606613159},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.49787163734436035},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4340433180332184},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.416848361492157},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3376438617706299},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2316155731678009},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.11088800430297852},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.05365779995918274}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/2326-6066.22538614","doi":"https://doi.org/10.1158/2326-6066.22538614","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538614","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2326-6066.22538614.v1","doi":"https://doi.org/10.1158/2326-6066.22538614.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538614.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22538614","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_1_-_4_from_Preexisting_Levels_of_CD4_T_Cells_Expressing_PD-1_Are_Related_to_Overall_Survival_in_Prostate_Cancer_Patients_Treated_with_Ipilimumab/22538614","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.22538614","doi":"https://doi.org/10.1158/2326-6066.22538614","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22538614","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133929618","https://openalex.org/W4392722476","https://openalex.org/W3014592760","https://openalex.org/W3203318233","https://openalex.org/W2074651601","https://openalex.org/W2601764482","https://openalex.org/W2328127617","https://openalex.org/W2075936080","https://openalex.org/W2053396704","https://openalex.org/W3047228036"],"abstract_inverted_index":{"Supplementary":[0,7,12,30],"Table":[1,8,13,31],"S1.":[2],"Patient":[3],"characteristics":[4],"by":[5],"cohort.":[6],"S2.":[9],"Treatment-related":[10],"toxicity.":[11],"S3.":[14],"Individual":[15],"clinical":[16],"response":[17],"of":[18,34,37],"patients":[19],"treated":[20],"with":[21],"ipilimumab":[22],"at":[23],"{greater":[24],"than":[25],"or":[26],"equal":[27],"to}":[28],"3mg/kg/dose.":[29],"S4.":[32],"Comparison":[33],"absolute":[35],"counts":[36],"T":[38],"cell":[39],"subsets":[40],"between":[41],"LTS":[42],"and":[43],"STS.":[44]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}